Haematopoietic stem cell transplantation for refractory autoimmune cytopenia

J. R. Passweg, M. Rabusin, M. Musso, Y. Beguin, S. Cesaro, G. Ehninger, I. Espigado, A. Iriondo, L. Jost, V. Koza, S. Lenhoff, I. Lisukov, F. Locatelli, A. Marmont, P. Philippe, C. Pilatrino, P. Quartier, J. Stary, P. Veys, J. VormoorA. Wahlin, F. Zintl, C. Bocelli-Tyndall, A. Tyndall, A. Gratwohl

Research output: Contribution to journalArticle

74 Citations (Scopus)

Abstract

This study describes the outcome of patients receiving haematopoietic stem cell transplantation (HSCT) to treat severe refractory autoimmune cytopenia. The registry of the European Group of Blood and Marrow Transplantation holds data on 36 patients receiving 38 transplants, the first transplant was autologous for 27 and allogeneic for nine patients. Patients had autoimmune haemolytic anaemia (autologous: 5; allogeneic: 2), Evans's syndrome (autologous: 2; allogeneic: 5); immune thrombocytopenia (autologous: 12), pure red cell aplasia (autologous: 4; allogeneic: 1), pure white cell aplasia (autologous: 1; allogeneic 1), or thrombotic thrombocytopenic purpura (autologous: 3). Patients had longstanding disease having failed multiple prior treatments. Among 26 evaluable patients mobilized for autologous HSCT, three died of treatment-related causes, one died of disease progression, seven were non-responders, six patients had transient responses and nine had continuous partial or complete remission. Of the seven evaluable patients receiving allogeneic HSCT, one died of treatment-related complications, one with transient response died of progressive disease and five had a continuous response. Autologous and allogeneic HSCT may induce a response in a subset of patients with autoimmune cytopenia of long duration albeit at the price of considerable toxicity.

Original languageEnglish
Pages (from-to)749-755
Number of pages7
JournalBritish Journal of Haematology
Volume125
Issue number6
DOIs
Publication statusPublished - Jun 2004

Fingerprint

Hematopoietic Stem Cell Transplantation
Pure Red-Cell Aplasia
Thrombotic Thrombocytopenic Purpura
Autoimmune Hemolytic Anemia
Idiopathic Thrombocytopenic Purpura
Autografts
Blood Group Antigens
Registries
Disease Progression
Therapeutics
Transplantation
Bone Marrow
Outcome Assessment (Health Care)
Transplants

Keywords

  • Allogeneic
  • Autoimmune cytopenia
  • Autologous
  • Evans's syndrome
  • Immune thrombocytopenia
  • Pure red cell aplasia
  • Stem cell transplantation

ASJC Scopus subject areas

  • Hematology

Cite this

Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. / Passweg, J. R.; Rabusin, M.; Musso, M.; Beguin, Y.; Cesaro, S.; Ehninger, G.; Espigado, I.; Iriondo, A.; Jost, L.; Koza, V.; Lenhoff, S.; Lisukov, I.; Locatelli, F.; Marmont, A.; Philippe, P.; Pilatrino, C.; Quartier, P.; Stary, J.; Veys, P.; Vormoor, J.; Wahlin, A.; Zintl, F.; Bocelli-Tyndall, C.; Tyndall, A.; Gratwohl, A.

In: British Journal of Haematology, Vol. 125, No. 6, 06.2004, p. 749-755.

Research output: Contribution to journalArticle

Passweg, JR, Rabusin, M, Musso, M, Beguin, Y, Cesaro, S, Ehninger, G, Espigado, I, Iriondo, A, Jost, L, Koza, V, Lenhoff, S, Lisukov, I, Locatelli, F, Marmont, A, Philippe, P, Pilatrino, C, Quartier, P, Stary, J, Veys, P, Vormoor, J, Wahlin, A, Zintl, F, Bocelli-Tyndall, C, Tyndall, A & Gratwohl, A 2004, 'Haematopoietic stem cell transplantation for refractory autoimmune cytopenia', British Journal of Haematology, vol. 125, no. 6, pp. 749-755. https://doi.org/10.1111/j.1365-2141.2004.04978.x
Passweg, J. R. ; Rabusin, M. ; Musso, M. ; Beguin, Y. ; Cesaro, S. ; Ehninger, G. ; Espigado, I. ; Iriondo, A. ; Jost, L. ; Koza, V. ; Lenhoff, S. ; Lisukov, I. ; Locatelli, F. ; Marmont, A. ; Philippe, P. ; Pilatrino, C. ; Quartier, P. ; Stary, J. ; Veys, P. ; Vormoor, J. ; Wahlin, A. ; Zintl, F. ; Bocelli-Tyndall, C. ; Tyndall, A. ; Gratwohl, A. / Haematopoietic stem cell transplantation for refractory autoimmune cytopenia. In: British Journal of Haematology. 2004 ; Vol. 125, No. 6. pp. 749-755.
@article{2d1ab94f148c4b2f85ad5a14b2cc0eed,
title = "Haematopoietic stem cell transplantation for refractory autoimmune cytopenia",
abstract = "This study describes the outcome of patients receiving haematopoietic stem cell transplantation (HSCT) to treat severe refractory autoimmune cytopenia. The registry of the European Group of Blood and Marrow Transplantation holds data on 36 patients receiving 38 transplants, the first transplant was autologous for 27 and allogeneic for nine patients. Patients had autoimmune haemolytic anaemia (autologous: 5; allogeneic: 2), Evans's syndrome (autologous: 2; allogeneic: 5); immune thrombocytopenia (autologous: 12), pure red cell aplasia (autologous: 4; allogeneic: 1), pure white cell aplasia (autologous: 1; allogeneic 1), or thrombotic thrombocytopenic purpura (autologous: 3). Patients had longstanding disease having failed multiple prior treatments. Among 26 evaluable patients mobilized for autologous HSCT, three died of treatment-related causes, one died of disease progression, seven were non-responders, six patients had transient responses and nine had continuous partial or complete remission. Of the seven evaluable patients receiving allogeneic HSCT, one died of treatment-related complications, one with transient response died of progressive disease and five had a continuous response. Autologous and allogeneic HSCT may induce a response in a subset of patients with autoimmune cytopenia of long duration albeit at the price of considerable toxicity.",
keywords = "Allogeneic, Autoimmune cytopenia, Autologous, Evans's syndrome, Immune thrombocytopenia, Pure red cell aplasia, Stem cell transplantation",
author = "Passweg, {J. R.} and M. Rabusin and M. Musso and Y. Beguin and S. Cesaro and G. Ehninger and I. Espigado and A. Iriondo and L. Jost and V. Koza and S. Lenhoff and I. Lisukov and F. Locatelli and A. Marmont and P. Philippe and C. Pilatrino and P. Quartier and J. Stary and P. Veys and J. Vormoor and A. Wahlin and F. Zintl and C. Bocelli-Tyndall and A. Tyndall and A. Gratwohl",
year = "2004",
month = "6",
doi = "10.1111/j.1365-2141.2004.04978.x",
language = "English",
volume = "125",
pages = "749--755",
journal = "British Journal of Haematology",
issn = "0007-1048",
publisher = "John Wiley & Sons, Ltd (10.1111)",
number = "6",

}

TY - JOUR

T1 - Haematopoietic stem cell transplantation for refractory autoimmune cytopenia

AU - Passweg, J. R.

AU - Rabusin, M.

AU - Musso, M.

AU - Beguin, Y.

AU - Cesaro, S.

AU - Ehninger, G.

AU - Espigado, I.

AU - Iriondo, A.

AU - Jost, L.

AU - Koza, V.

AU - Lenhoff, S.

AU - Lisukov, I.

AU - Locatelli, F.

AU - Marmont, A.

AU - Philippe, P.

AU - Pilatrino, C.

AU - Quartier, P.

AU - Stary, J.

AU - Veys, P.

AU - Vormoor, J.

AU - Wahlin, A.

AU - Zintl, F.

AU - Bocelli-Tyndall, C.

AU - Tyndall, A.

AU - Gratwohl, A.

PY - 2004/6

Y1 - 2004/6

N2 - This study describes the outcome of patients receiving haematopoietic stem cell transplantation (HSCT) to treat severe refractory autoimmune cytopenia. The registry of the European Group of Blood and Marrow Transplantation holds data on 36 patients receiving 38 transplants, the first transplant was autologous for 27 and allogeneic for nine patients. Patients had autoimmune haemolytic anaemia (autologous: 5; allogeneic: 2), Evans's syndrome (autologous: 2; allogeneic: 5); immune thrombocytopenia (autologous: 12), pure red cell aplasia (autologous: 4; allogeneic: 1), pure white cell aplasia (autologous: 1; allogeneic 1), or thrombotic thrombocytopenic purpura (autologous: 3). Patients had longstanding disease having failed multiple prior treatments. Among 26 evaluable patients mobilized for autologous HSCT, three died of treatment-related causes, one died of disease progression, seven were non-responders, six patients had transient responses and nine had continuous partial or complete remission. Of the seven evaluable patients receiving allogeneic HSCT, one died of treatment-related complications, one with transient response died of progressive disease and five had a continuous response. Autologous and allogeneic HSCT may induce a response in a subset of patients with autoimmune cytopenia of long duration albeit at the price of considerable toxicity.

AB - This study describes the outcome of patients receiving haematopoietic stem cell transplantation (HSCT) to treat severe refractory autoimmune cytopenia. The registry of the European Group of Blood and Marrow Transplantation holds data on 36 patients receiving 38 transplants, the first transplant was autologous for 27 and allogeneic for nine patients. Patients had autoimmune haemolytic anaemia (autologous: 5; allogeneic: 2), Evans's syndrome (autologous: 2; allogeneic: 5); immune thrombocytopenia (autologous: 12), pure red cell aplasia (autologous: 4; allogeneic: 1), pure white cell aplasia (autologous: 1; allogeneic 1), or thrombotic thrombocytopenic purpura (autologous: 3). Patients had longstanding disease having failed multiple prior treatments. Among 26 evaluable patients mobilized for autologous HSCT, three died of treatment-related causes, one died of disease progression, seven were non-responders, six patients had transient responses and nine had continuous partial or complete remission. Of the seven evaluable patients receiving allogeneic HSCT, one died of treatment-related complications, one with transient response died of progressive disease and five had a continuous response. Autologous and allogeneic HSCT may induce a response in a subset of patients with autoimmune cytopenia of long duration albeit at the price of considerable toxicity.

KW - Allogeneic

KW - Autoimmune cytopenia

KW - Autologous

KW - Evans's syndrome

KW - Immune thrombocytopenia

KW - Pure red cell aplasia

KW - Stem cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=3042588237&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042588237&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2141.2004.04978.x

DO - 10.1111/j.1365-2141.2004.04978.x

M3 - Article

C2 - 15180864

AN - SCOPUS:3042588237

VL - 125

SP - 749

EP - 755

JO - British Journal of Haematology

JF - British Journal of Haematology

SN - 0007-1048

IS - 6

ER -